Company profile for Harbin Pharmaceutical Group Co., Ltd.

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

HARBIN PHARMACEUTICAL GROUP CO.?LTD. General Pharm. Factory (HGPF) is located in beautiful ice city - Harbin and established in 1958. HGPF is a subsidiary company of HARBIN PHARMACEUTICAL GROUP Co. Ltd. (HGPC) and is a key manufacture base of antibiotics in China. What's more, she is one of TOP 500 Industry Enterprises in China. The brand value of 'HaYao'(HPGC) is 18.365 billion RMB in 2012. HPGC has ranked No.1 of the Most Va...
HARBIN PHARMACEUTICAL GROUP CO.?LTD. General Pharm. Factory (HGPF) is located in beautiful ice city - Harbin and established in 1958. HGPF is a subsidiary company of HARBIN PHARMACEUTICAL GROUP Co. Ltd. (HGPC) and is a key manufacture base of antibiotics in China. What's more, she is one of TOP 500 Industry Enterprises in China. The brand value of 'HaYao'(HPGC) is 18.365 billion RMB in 2012. HPGC has ranked No.1 of the Most Valuable Chinese Brand List since 8 years ago and has become the most famous brand in Heilongjiang Province.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
No 109 Xuefu Road Nangang District
Telephone
Telephone
86 866 782 66
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://endpts.com/arcus-grabs-us-rights-to-a-wuxi-built-pd-1-as-second-wave-of-checkpoints-builds/

John Carroll END POINTS
18 Aug 2017
Wuxi Biologics files IPO prospectus aiming to be gateway to China
Wuxi Biologics files IPO prospectus aiming to be gateway to China

26 Jan 2017

// Gareth MacDonald BIOPHARMA REPORTER

http://www.biopharma-reporter.com/Markets-Regulations/Wuxi-Biologics-files-IPO-prospectus-aiming-to-be-gateway-to-China

Gareth MacDonald BIOPHARMA REPORTER
26 Jan 2017

ABOUT THIS PAGE

Contact Harbin Pharmaceutical Group Co., Ltd and get a quotation

Harbin Pharmaceutical Group Co., Ltd is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of Cefotiam Hydrochloride bulk with JDMF offered by Harbin Pharmaceutical Group Co., Ltd

Find a price of 6-Aminopenicillanic Acid bulk offered by Harbin Pharmaceutical Group Co., Ltd

Find a price of Penicillin G Potassium bulk offered by Harbin Pharmaceutical Group Co., Ltd

Find a price of Ceftriaxone bulk offered by Harbin Pharmaceutical Group Co., Ltd

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty